Top of the Street: Compass, Novartis, European consumer staples
09/07/2020 13:36
A round-up of notable broker activity this morning from
Europe's top-ranked* analysts:
** RBC cuts Compass CPG.L to "underperform" from "sector
perform" as many uncertainties arising from continuously rising
COVID-19 case numbers make the British caterer's valuation too
expensive urn:newsml:reuters.com:*:nL4N2EG1R6
** In the European pharmaceutical sector, Novartis NOVN.S
is Jefferies' preferred EU large-cap; the broker sees scope for
further appreciation, citing the company's confidence in the
potential success of its breast cancer drug Kisqali urn:newsml:reuters.com:*:nL8N2EG27T
** Credit Suisse names Unilever UNA.AS , BAT BATS.L ,
Danone DANO.PA and Essity ESSITYa.ST as its top picks in the
European consumer staples sector, noting that some management
teams are proving faster at reacting to change urn:newsml:reuters.com:*:nL8N2EG1LJ
** Among Switzerland-listed technology and industrial
stocks, CS sees Daetwyler DAE.S , Forbo FORN.S , Georg Fischer
FIN.S , Klingelnberg KLIN.S and Landis+Gyr LANDI.S as
particularly attractive and rates all "outperform", but it
continues to be cautious on Sensirion SENSI.S ("underperform")
urn:newsml:reuters.com:*:nL8N2EG1BU
(*Analyst rankings from Thomson Reuters StarMine. The scale is
from 1-star to 5-star with 5 being the best. Analysts are ranked
on earnings accuracy as well as relative performance of
recommendations over trailing 12-month & 24-month periods.)
((elizaveta.gladun@thomsonreuters.com ;
antonis.pothitos@thomsonreuters.com))